Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital

References

• Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K. Health care-associated invasive MRSA infections, 2005–2008. JAMA 2010;304:641–8.
   PubMed Web of Science ®Google Scholar
• Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA 2009;301:727–36.
   PubMed Web of Science ®Google Scholar
• Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary care centre. Clin Microbiol Infect 2006;12:345–52.
   PubMed Web of Science ®Google Scholar
• Libert M, Elkhoti M, Massaut J, Karmali R, Mascart G, Cherifi S. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 2008;68:17–24.
   PubMedGoogle Scholar
• Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012–21.
   PubMed Web of Science ®Google Scholar
• Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46:232–42.
   PubMed Web of Science ®Google Scholar
• Haro JL, Lomas JM, Plata A, Ruiz J, Gálvez J, de la Torre J. Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease. Enferm Infecc Microbiol Clin 2008;26:263–8.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM. Relationship between vancomyin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315–20.
   PubMed Web of Science ®Google Scholar
• Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46:193–200.
   PubMed Web of Science ®Google Scholar
• Jones RN. Microbiological features of vancomycin in the 21st century. Minimum inhibitory concentration creep, bactericidal/static activity and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006;42:S13–24.
   PubMed Web of Science ®Google Scholar
• Chang WN, Lu CH, Huang CR, Chuang YC, Tsai NW, Chen SF. Epidemiology of adult staphylococcal meningitis in southern Taiwan: a clinical comparison of Staphylococcus aureus infection and coagulase-negative staphylococcal infection. Jpn J Infect Dis 2007;60: 262–6.
   PubMedGoogle Scholar
• Laguna-Del Estal P, Castaneda-Pastor A, Gil-Navarro M, Garcia-Madero R, Lopez-Cano Gomez M, Agud-Fernandez M. Comparative study of meningitis due to Staphylococcus aureus and coagulase-negative staphylococci in adults. Rev Neurol 2009;48:2–6.
   PubMedGoogle Scholar
• Danese MD, Griffiths RI, Dylan M, Yu HT, Dubois R, Nissenson AR. Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 2006; 10:56–62.
   PubMedGoogle Scholar
• Topeli A, Unal S, Hayran M, Akalin HE. Septic shock as a predictor of mortality in bacteremia caused by coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 1997; 16:411–6.
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MT, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53–9.
   PubMed Web of Science ®Google Scholar
• Lodise TP, McKinnon PS, Levine DP, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:3731–3.
   PubMed Web of Science ®Google Scholar
• Fowler VG, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003;163:2066–72.
   PubMed Web of Science ®Google Scholar
• Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality and clinical impact of methicillin resistance. Medicine (Baltimore) 2003;82:322–32.
   PubMed Web of Science ®Google Scholar
• Comite de L'antibiogramme de la Societe Francaise de Microbiologie. Recommandations 2010 (Edition de Janvier 2010) Copyright 2010 – Société Française de Microbiologie Coordonnateur: Pr C.J. SOUSSY Centre Hospitalier Universitaire Henri Mondor 94010 Creteil Cedex http://www.sfm-microbiologie.org/Userfiles/file/CASFM/casfm_2010.pdf accessed 22/09/2011.
   Google Scholar
• Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003;24: 890–6.
   PubMed Web of Science ®Google Scholar
• Levy M, Fink M, Marshall JC, Abraham E, Angus D, Cook D. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–8.
   PubMedGoogle Scholar
• Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O'Connel B. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005;26: 204–9.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249–72.
   PubMed Web of Science ®Google Scholar
• Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633–8.
   PubMed Web of Science ®Google Scholar
• Bourneton O, Mutel T, Heranney D, Hernandez C, Lavigne T, Waller J. Incidence of hospital-acquired and community-acquired bloodstream infections in the University of Strasbourg Hospital, France, between 2005 and 2007. Pathol Biol (Paris) 2010;58:29–34.
   PubMedGoogle Scholar
• Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995–2002. Epidemiol Infect 2008;136:108–14.
   PubMed Web of Science ®Google Scholar
• Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P. Nosocomial bloodstream infections in Finnish Hospitals during 1999–2000. Clin Infect Dis 2002;35:e14–9.
   PubMed Web of Science ®Google Scholar
• Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T. Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin Microbiol Infect 2011;17:451–8.
   PubMed Web of Science ®Google Scholar
• Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002;2:677–85.
   PubMed Web of Science ®Google Scholar
• Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM. Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003;82:333–9.
   PubMed Web of Science ®Google Scholar
• Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower res-piratory tract infections. Clin Pharmacokinet 2004;43: 925–42.
   PubMed Web of Science ®Google Scholar
• Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Efficacy and toxicity. Arch Intern Med 2006;166:2138–44.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Lomaestro BM, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330–6.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration–time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507–14.
   PubMed Web of Science ®Google Scholar
• Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia. Chest 2006;130:947–55.
   PubMed Web of Science ®Google Scholar
• Wunderink R, Rello J, Cammarata SK, Croos-Dabrera R, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124: 1789–97.
   PubMed Web of Science ®Google Scholar
• Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. J Antimicrob Chemother 2008; 62:1413–21.
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325–7.
   PubMed Web of Science ®Google Scholar
• Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 1998;19:581–9.
   PubMed Web of Science ®Google Scholar
• Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D. Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol 2005;26:697–702.
   PubMed Web of Science ®Google Scholar